Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retosiban vs Atosiban in Spontaneous Preterm Labor
NCT02292771Phase 3Terminated
- Sponsor
- GSK
- Start
- Mar 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of retosiban in spontaneous preterm labor (SPTL), sponsored by GSK. Started Mar 2015; status: terminated.
02
Drugs
retosiban
03
Conditions
spontaneous preterm labor (SPTL)
Beyond the preview
Go deeper on NCT02292771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02292771.